Aier Eye Valuation
| 300015 Stock | 13.74 0.24 1.72% |
At this time, the firm appears to be overvalued. Aier Eye Hospital shows a prevailing Real Value of USD12.42 per share. The current price of the firm is USD13.74. Our model approximates the value of Aier Eye Hospital from analyzing the firm fundamentals such as profit margin of 0.18 %, and Return On Equity of 0.18 as well as examining its technical indicators and probability of bankruptcy.
Price Book 6.2811 | Enterprise Value 128.8 B | Enterprise Value Ebitda 26.6375 | Price Sales 6.2145 | Trailing PE 35.2308 |
Overvalued
Today
Please note that Aier Eye's price fluctuation is not too volatile at this time. Calculation of the real value of Aier Eye Hospital is based on 3 months time horizon. Increasing Aier Eye's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Aier Eye is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aier Stock. However, Aier Eye's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 13.74 | Real 12.42 | Hype 13.74 | Naive 14.12 |
The real value of Aier Stock, also known as its intrinsic value, is the underlying worth of Aier Eye Hospital Company, which is reflected in its stock price. It is based on Aier Eye's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Aier Eye's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Aier Eye Hospital helps investors to forecast how Aier stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aier Eye more accurately as focusing exclusively on Aier Eye's fundamentals will not take into account other important factors: Aier Eye Cash |
|
Aier Eye Total Value Analysis
Aier Eye Hospital is presently estimated to have takeover price of 128.76 B with market capitalization of 128.15 B, debt of 5.6 B, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aier Eye fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
128.76 B | 128.15 B | 5.6 B |
Aier Eye Investor Information
About 55.0% of the company shares are owned by insiders or employees . The company has Price/Earnings To Growth (PEG) ratio of 1.65. Aier Eye Hospital last dividend was issued on the 6th of June 2024. The entity had 1.300045:1 split on the 8th of June 2023. Based on the measurements of operating efficiency obtained from Aier Eye's historical financial statements, Aier Eye Hospital is performing exceptionally good at this time. It has a great probability to report excellent financial results in April.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 7.1 B | 6.8 B |
|
| |||||
| Operating Income | 6.7 B | 6.4 B |
|
|
Aier Eye Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Aier Eye has an asset utilization ratio of 67.47 percent. This suggests that the Company is making USD0.67 for each dollar of assets. An increasing asset utilization means that Aier Eye Hospital is more efficient with each dollar of assets it utilizes for everyday operations.Aier Eye Ownership Allocation
Aier Eye holds a total of 9.33 Billion outstanding shares. Aier Eye Hospital retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aier Eye Profitability Analysis
The company reported the revenue of 20.37 B. Net Income was 3.36 B with profit before overhead, payroll, taxes, and interest of 10.33 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Aier Eye's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Aier Eye and how it compares across the competition.
About Aier Eye Valuation
The stock valuation mechanism determines Aier Eye's current worth on a weekly basis. Our valuation model uses a comparative analysis of Aier Eye. We calculate exposure to Aier Eye's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aier Eye's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 11.9 B | 12.5 B |
Aier Eye Quarterly Retained Earnings |
|
Complementary Tools for Aier Stock analysis
When running Aier Eye's price analysis, check to measure Aier Eye's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aier Eye is operating at the current time. Most of Aier Eye's value examination focuses on studying past and present price action to predict the probability of Aier Eye's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aier Eye's price. Additionally, you may evaluate how the addition of Aier Eye to your portfolios can decrease your overall portfolio volatility.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |